Guidance for salmonella in peanut products
This article was originally published in The Tan Sheet
FDA issues guidance to assist manufacturers of products containing peanut ingredients in avoiding contamination by salmonella bacteria. The March 11 guidance advises firms to "obtain peanut-derived product only from suppliers with validated processes in place to adequately reduce the presence of salmonella." FDA suggests companies not rely on a history of negative microbiological tests for salmonella in finished peanut product, as this does not ensure the adequacy of a supplier's procedures for controlling bacteria. Peanut-containing products recalled recently in the salmonella outbreak include nutritional bars, though industry experts say dietary supplement ingredients generally do not harbor harmful bacteria (1"The Tan Sheet" Jan. 26, 2009, p. 8)
You may also be interested in...
FDA publishes draft guidance addressing the risk of salmonella contamination in pistachio-derived ingredients. The agency will accept comments on the guidance until Aug. 28, according to a June 29 Federal Register notice. FDA published a guidance on avoiding salmonella contamination of peanut products in March (1"The Tan Sheet" March 16, 2009, In Brief)
Safeguards in place in the dietary supplement industry would prevent or quickly contain a crisis like the current spate of recalls of peanut butter-containing products now facing the food industry, supplement experts say
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.